VKTX
Price
$32.65
Change
+$0.09 (+0.28%)
Updated
Jan 17 closing price
Capitalization
3.64B
18 days until earnings call
XLO
Price
$1.14
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
52.12M
39 days until earnings call
Ad is loading...

VKTX vs XLO

Header iconVKTX vs XLO Comparison
Open Charts VKTX vs XLOBanner chart's image
Viking Therapeutics
Price$32.65
Change+$0.09 (+0.28%)
Volume$4.39M
Capitalization3.64B
Xilio Therapeutics
Price$1.14
Change-$0.00 (-0.00%)
Volume$164.38K
Capitalization52.12M
VKTX vs XLO Comparison Chart
Loading...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VKTX vs. XLO commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VKTX is a Hold and XLO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (VKTX: $32.65 vs. XLO: $1.14)
Brand notoriety: VKTX and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VKTX: 117% vs. XLO: 31%
Market capitalization -- VKTX: $3.64B vs. XLO: $52.12M
VKTX [@Biotechnology] is valued at $3.64B. XLO’s [@Biotechnology] market capitalization is $52.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VKTX’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • VKTX’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, XLO is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VKTX’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 5 bullish TA indicator(s).

  • VKTX’s TA Score: 4 bullish, 3 bearish.
  • XLO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than XLO.

Price Growth

VKTX (@Biotechnology) experienced а -16.94% price change this week, while XLO (@Biotechnology) price change was +3.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

VKTX is expected to report earnings on Apr 23, 2025.

XLO is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.64B) has a higher market cap than XLO($52.1M). XLO YTD gains are higher at: 19.372 vs. VKTX (-18.862). XLO has higher annual earnings (EBITDA): -62.43M vs. VKTX (-133.66M). VKTX has more cash in the bank: 930M vs. XLO (61.3M). VKTX has less debt than XLO: VKTX (1.24M) vs XLO (8.42M). XLO has higher revenues than VKTX: XLO (4.62M) vs VKTX (0).
VKTXXLOVKTX / XLO
Capitalization3.64B52.1M6,983%
EBITDA-133.66M-62.43M214%
Gain YTD-18.86219.372-97%
P/E RatioN/AN/A-
Revenue04.62M-
Total Cash930M61.3M1,517%
Total Debt1.24M8.42M15%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VKTXXLO
RSI
ODDS (%)
Bullish Trend 11 days ago
76%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
83%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
70%
MACD
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 11 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 11 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
78%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTDTX15.710.14
+0.90%
Russell Inv Multifactor US Equity M
RWMAX62.020.48
+0.78%
American Funds Washington Mutual R1
INTIX11.200.04
+0.36%
Voya International Index Port S
AAASX11.780.03
+0.26%
DWS RREEF Real Assets S
TOVYX15.460.04
+0.26%
American Beacon EAM Int Small Cap Y

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+0.28%
JANX - VKTX
61%
Loosely correlated
+0.27%
DNLI - VKTX
49%
Loosely correlated
+1.20%
LGND - VKTX
44%
Loosely correlated
+0.73%
BEAM - VKTX
41%
Loosely correlated
+0.17%
ALT - VKTX
40%
Loosely correlated
+2.24%
More

XLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XLO has been loosely correlated with AVTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XLO jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
N/A
AVTX - XLO
35%
Loosely correlated
+0.30%
CRMD - XLO
31%
Poorly correlated
-4.85%
AXON - XLO
31%
Poorly correlated
+1.37%
VKTX - XLO
30%
Poorly correlated
+0.28%
VTGN - XLO
29%
Poorly correlated
N/A
More